Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared to Originator Product in Patients with Neovascular Age-related Macular Degeneration.
Karkhaneh R, Faghihi H, Riazi-Esfahani H, Abrishami M, Bazvand F, Ebrahimiadib N, Johari M, Akhlaghi M, Shoeibi N, Norouzzadeh MH, Ansari Astaneh MR, Khojasteh H, Imani Fooladi M, Khodabande A, Ghassemi F, Khalili Pour E, Zarei M, Mirshahi A, Fazel F, Ashraf H, Hosseini SM, Dourandeesh M, Feghhi M, Alizadeh Y, Behboudi H, Azadi P, Sabzvari A, Kafi H, Ghasemi Falavarjani K.
Karkhaneh R, et al. Among authors: hosseini sm.
Ophthalmol Retina. 2024 Feb 28:S2468-6530(24)00081-2. doi: 10.1016/j.oret.2024.02.012. Online ahead of print.
Ophthalmol Retina. 2024.
PMID: 38428459